We perfo rm ed a retrospecti ve chart re view of55 p ati ents who had been treat edfor head andneck cancer to evaluate the comp lication rat e asso ciated with p ercutaneous endoscopic gastrostomy (PEG)for nutritionalsuppo rt. Wefound that comp lications occurred in only 6 patient s (/0.9 %) ; 3 ofthese patient s (5.5%) had granulation around the site ofthe PEG tub e, and 1 eac h exp erienced a tub e tnalfunction , migration ofthe PEG tub e, and leakage around the tub e. No wound infection or othe r co mp lication ass ociat ed with PEG tub es was noted. Ofthe 6 complic ations, 3 occurred in 31 patients who underwent PEG tub e placem ent at the tim e oftum or resecti on, and 3 occurred am ong 16 patients who received a PEG tub e po stoperatively. We conclude that placement ofa PEG tub e is a safe meth od ofproviding nonoral nutritional s uppo rt/ or patients with head and neck cancel:
Introduction
Patients with head and neck cancer are often nutritionally depleted. Factors that contribute to this depl eti on include dysphagia, od ynophagia , cachexia associated with cancer, and the morbidity associated with surgery, chemotherap y, and radiation therapy. These factors can contribute to a 10% or greater loss of baseline body weight during treatment. ' Traditionally, placement of a nasog astric tube has been the primary feeding modality for these patients. ' complications-notably, laryn geal irrit ation and persistent gastroesophageal reflux. Th e percutaneous endo scopic gastrostomy (PEG) tube is an alternative to the nasogastric tube . Its use was first described by Gau de rer et al in 1980. 3 Reported complication rates during PEG have been highly variable, ranging from 5 to 40 % . [4] [5] [6] [7] [8] [9] [10] [11] [12] In 200 I, Mekhail et al concluded that the risks of PEG are too high in pati ents with head and neck cancer, and they called for further investigations to determine its role.'
In this article, we describe ou r study of the incidence and type of complications associated with PEG in patients wh o were treated for head and neck cancer at an urban teaching hospital.
Patients and methods
We performed a retrospective review of the charts of 55 pati ent s---44 men and II women, aged 43 to 83 years (me an : 6 1± II )-with squamous cell carcinoma of the head and neck who had undergone a PEG procedure between Jan . I, 1995, and Aug. 30, 200 I. All PEG s had been performed in the Department ofSurgery at University Hospital, which is affiliated with the ·New Jersey Medical Sch ool in Newark.
In addition to recording specific complications, we not ed oth er factors such as tumor location and stage , the time of PEG tub e placement relative to the time of tumor resection , and the time of the onset of complications. All PEGs had been performed in the op erating room with the patient und er gene ral anesthesia. Th e standard pull method oftube pla cement was used with one modification: the tube was insert ed into the abdomen through a 3-cm incision rather than through a standard puncture op ening.
Results
Lesion site. Th e most common site ofthe malignant lesion (20 .0% of all cases) was the base of the tongue (tabl e) .
Type ofcomplications. Complications occurred in only 6 patients (10.9%). The most common complication was the formation of granulation tissue arou nd the PEG tube, wh ich occurred in 3 patients (5.5%). One patient (1.8%) experienced a tube ma lfunction, another experienced migration of the tube, and I experienced leakage around the tube. No wound infection or other co mplication associated with PEG was noted.
Time oftube placement. Thirty-one patients underwent PEG hlbe placement at the time of tumor resection (i.e., intraoperatively). In all but I of these patients, the tube was inserted immediately preceding resection. Three of these patients experienced complications-2 developed granulatio n tissue and I experienced tube migration (the tube was subsequently readjusted). Sixteen patients underwent tube placement postoperatively, and 3 experienced complications-I had the tube ma lfunction, I developed granulation tissue, and I experienced leakage.
Of the rema ining 8 patients , I underwent tube placement preoperative ly and 7 were treated nonsurgically. None experienced a comp lication.
Time ofonset. The onset of the 3 cases of gran ulat ion tiss ue occ urred at 3,8, and 73 weeks following PEG. The tube ma lfunction, the migration, and the leakage occurred at 4 weeks, 6 weeks, and 19 weeks, respectively. All but I of these complications occurred within 5 months of tube placement. 
Discussion
The optimal method of providing nonoral nutritional support for patients with head and neck cancer is unc lear. Both long-term nasogastric tubes and PEG tubes have been used . PEG tubes offer pote ntia l advantages over nasogastric tubes in that their use can result in a decrease in the length of hospital stay (a 61% decrease among patients with tongue-base, laryngeal, and tonsillar lesions, according to one study! '), an increase in patient comfort,':' improvement in nutritional status," and a more favorable cosmetic outcome." On the other hand, the use ofPEG tubes has been reported to possibly promote a longer period ofnon oral feeding secondary to the deconditioning ofthe muscles ofdeglutition. 7 A lso, concerns have been raised abo ut pre mature removal,' wound infection at the site,5.8.10 and other comp lications, such as leakage, aspiration, and peritonitis. Less common complications include tumor implantation,!1.I2 gastric perforation, gastric bleeding, and gastrocolic fistula.
In 1999, Walton reported a major complication rate of 22.5% and a minor complication rate of 17.5%.5 The primary major complication was premature tube removal and the primary minor complication was wound infection. In our study, the complication rate (10 .9%) was re latively low, and none of these comp lications included premature tube removal or wound infection.
Wound infection has been identified as the most common complication by several invesrigators.v'?We believe that the lack of wo und infections in our study may be attributable to the fact that the incision made in the abdominal skin of these patients was larger than usual. Bacteria are less likely to become trapped in larger incisions.
Twelve cases of implantation of tumor at the PEG site have been reported.!':" In these cases, tumor may have been seeded in the abdominal wa ll when the catheter was pulled through the aerodigestive tract. We did not compare our patients to a matched group of patients with nasogastric tubes, but a comparison with the findings ofothers may be instructive, For examp le, the mean length of stay for patients with tongue-base les ions 
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We conclude that the use of PEG tube s is a safe method of deliv erin g nonoral nutritional supp ort for patients with head and neck cancer and that the complication rate is acceptable.
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